Phase 3 study of ivosidenib vs placebo in locally advanced or metastatic IDH1-mutant conventional chondrosarcoma untreated or previously treated with 1 systemic treatment regimen (CHONQUER).
Andrew J. Wagner, Silvia Stacchiotti, C. Debruyne, Abdulazeez Salawu, Jean Yves Blay, Fernando Augusto Batista Campos, Hiroaki Hiraga, Antoine Italiano, Akira Kawai, Ganessan Kichenadasse, Yoshihiro Nishida, Seth M. Pollack, Zhe Qu, Evinaa Sellaiah, Ilona Tala, Gabriel Tinoco, Jonathan C. Trent, Karina Costa Maia Vianna, Kan Yonemori, William D. Tap (2025). Phase 3 study of ivosidenib vs placebo in locally advanced or metastatic IDH1-mutant conventional chondrosarcoma untreated or previously treated with 1 systemic treatment regimen (CHONQUER).. , 43(16_suppl), DOI: https://doi.org/10.1200/jco.2025.43.16_suppl.tps11582.
